1 withdrawn. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Withdrawn 1 |
Follow Hyperphagia: new trials by email Literature Review of Hyperphagia trials Research Report on Hyperphagia
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study of Tesomet With Open-label Extension in Subjects With Prader-Willi Syndrome Placebo, Tesomet - Prader-Willi Syndrome | Phase 2 | Withdrawn | Saniona | 2021-12-28 | 2022-12-13 |
Abnormalities, Multiple (1) · Chromosome Disorders (1) · Congenital Abnormalities (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Genetic Diseases, Inborn (1) · Imprinting Disorders (1) · Intellectual Disability (1) · Nervous System Diseases (1) · Neurobehavioral Manifestations (1) · Neurologic Manifestations (1) · Nutrition Disorders (1) · Nutritional and Metabolic Diseases (1) · Obesity (1) · Overnutrition (1) · Overweight (1)
Metoprolol (1) · Tesofensine (1)
Saniona (1)
United States (1)